Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-01-02FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approves a supplemental application for omeprazole from Quallent Pharmaceuticals Health LLC, authorizing an additional formulation/produ…
-
FDA approval · 2014-12-21FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for pantoprazole submitted by NorthStar RxLLC under the ANDA pathway.
-
FDA approval · 2014-12-19FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to add the intravenous form of Protonix (pantoprazole sodium) to Wyeth/Pfizer's product line, expand…
-
FDA approval · 2014-12-19FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2014-12-19FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) by Takeda Pharmaceuticals America, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-12-19FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for omeprazole and sodium bicarbonate from Oceanside Pharmaceuticals, likely reflecting a labeling o…
-
FDA approval · 2014-12-19FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for omeprazole and sodium bicarbonate from Oceanside Pharmaceuticals, indicating an approved change …
-
FDA approval · 2014-12-19FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)
FDA approved a supplemental application for esomeprazole strontium from R2 Pharma, LLC, granting approval of this salt form under NDA 202342…
-
FDA approval · 2014-12-19FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for PREVACID (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2014-12-19FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) submitted by Wyeth Pharmaceuticals (Pfizer). …
-
FDA approval · 2014-12-19FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Dexilant (dexlansoprazole) by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2014-12-12FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
The FDA approved Apotex Corp's supplemental application for a generic omeprazole product.
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia [Phase 4]
Phase 4 trial completion reporting the evaluation of anti-reflux surgery for gastroesophageal reflux disease in premature infants with bronc…
-
FDA approval · 2014-12-10FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for metoclopramide from Teva Pharmaceuticals USA, Inc., authorizing changes to the product's labelin…
-
FDA approval · 2014-12-10FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Pantoprazole Sodium from Lannett Company, Inc., confirming the generic version of this product.
-
FDA approval · 2014-12-05FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pantoprazole sodium from Torrent Pharmaceuticals Limited, marking an update to the product's app…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Efficacy of a Dietary Supplementation With Lactobacillus Reuteri for Digestive Health in an Elderly Population [Phase 3]
Phase 3 trial evaluating Lactobacillus reuteri dietary supplementation for digestive health in elderly individuals has completed. The study …
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Clinical Studies on Bile Acids in Barrett's Esophagus [NA]
A completed clinical trial evaluating bile acids in Barrett's esophagus related to gastroesophageal reflux disease has posted results in 201…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: HEP-FYN 12-Years Follow-up [NA]
This clinical trial update provides long-term follow-up data (12 years) from the HEP-FYN study, related to peptic ulcer disease, dyspepsia, …
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER) [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating lansoprazole for gastroesophageal reflux in preterm infants has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances [Phase 4]
Phase 4 clinical trial comparing esomeprazole plus alginate versus esomeprazole alone for nighttime reflux symptoms and sleep disturbances; …
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Minimally Invasive Collis-Nissen for the Treatment of Short Esophagus [NA]
This clinical trial update reports the completed study evaluating the minimally invasive Collis-Nissen procedure for treating short esophagu…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Reletex for Nausea in GERD Patients [NA]
The clinical trial evaluating Reletex for nausea in patients with gastroesophageal reflux disease was terminated, and results were posted in…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms
This trial_result reports the completed surveillance study of lansoprazole tablets for gastroesophageal reflux disease with dyspepsia sympto…
-
CLINICAL_TRIALS research · 2014-11-07Clinical Trial Update: Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines [NA]
This trial update from Universidade Nova de Lisboa describes a study evaluating the effectiveness of educational outreach in prescription gu…